TMThermo Fisher Scientific TMO · NYSE
$687.59 +1.21% (+$8.21)
- Market cap
- $254.2B
- Enterprise value
- $292.7B
- P/E
- 36.4x
- Forward P/E
- 26.8x
- PEG
- 5.9x
- P/S
- 5.5x
- P/FCF
- 34.7x
- EV/EBITDA
- 26.8x
- ROIC
- 7.5%
- Gross margin
- 40.4%
- Net margin
- 15.1%
- Dividend yield
- 0.27%
- Payout ratio
- 9.7%
- Net debt/EBITDA
- 3.5x
- Beta
- 0.88
- Free float
- 99.8%
About the company
Thermo Fisher Scientific Inc. (TMO) is a global biotechnology company focusing on providing a wide range of laboratory technologies, scientific products, and services. The company is a leader in research and development, diagnostics, pharmaceuticals, and biotechnology. Thermo Fisher Scientific offers advanced products for the analysis of DNA, proteins, drugs, and other biological molecules, enabling accelerated scientific discovery and providing customers with tools to improve human health. With its global presence, strong research background, and innovative approach, the company has the potential for further growth and expanding its portfolio of scientific technologies. Investing in Thermo Fisher Scientific Inc. (TMO) shares can be an attractive choice for investors seeking a promising company with high research potential and impact on improving healthcare and scientific knowledge.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Marc N. Casper
Employees
125,000
Headquarters
Waltham
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number